Cutter Capital Management as of Sept. 30, 2024
Portfolio Holdings for Cutter Capital Management
Cutter Capital Management holds 27 positions in its portfolio as reported in the September 2024 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Gilead Sciences (GILD) | 8.9 | $30M | 359k | 83.84 | |
Bristol Myers Squibb (BMY) | 8.8 | $30M | 574k | 51.74 | |
Royalty Pharma Shs Class A (RPRX) | 5.6 | $19M | 665k | 28.29 | |
Agilent Technologies Inc C ommon (A) | 5.3 | $18M | 121k | 148.48 | |
Ultragenyx Pharmaceutical (RARE) | 4.7 | $16M | 287k | 55.55 | |
Legend Biotech Corp Sponsored Ads (LEGN) | 4.7 | $16M | 326k | 48.73 | |
Insmed Com Par $.01 (INSM) | 4.7 | $16M | 216k | 73.00 | |
Eli Lilly & Co. (LLY) | 4.5 | $15M | 17k | 885.94 | |
Regeneron Pharmaceuticals (REGN) | 4.5 | $15M | 15k | 1051.24 | |
Harmony Biosciences Hldgs In (HRMY) | 4.4 | $15M | 376k | 40.00 | |
Perrigo SHS (PRGO) | 4.3 | $15M | 558k | 26.23 | |
Jazz Pharmaceuticals Shs Usd (JAZZ) | 3.9 | $13M | 118k | 111.41 | |
Springworks Therapeutics (SWTX) | 3.6 | $12M | 379k | 32.04 | |
Miragen Therapeutics (VRDN) | 3.5 | $12M | 519k | 22.75 | |
Sarepta Therapeutics (SRPT) | 3.1 | $11M | 84k | 124.89 | |
Bridgebio Pharma (BBIO) | 3.0 | $10M | 396k | 25.46 | |
Axsome Therapeutics (AXSM) | 2.8 | $9.5M | 106k | 89.87 | |
Agios Pharmaceuticals (AGIO) | 2.4 | $8.3M | 187k | 44.43 | |
Iovance Biotherapeutics (IOVA) | 2.4 | $8.2M | 876k | 9.39 | |
Intellia Therapeutics (NTLA) | 2.4 | $8.0M | 391k | 20.55 | |
Vera Therapeutics Cl A (VERA) | 2.3 | $7.6M | 173k | 44.20 | |
Arcellx Common Stock (ACLX) | 2.2 | $7.5M | 90k | 83.51 | |
Avidity Biosciences Ord (RNA) | 2.2 | $7.4M | 161k | 45.93 | |
BioCryst Pharmaceuticals (BCRX) | 1.8 | $6.1M | 798k | 7.60 | |
Enliven Therapeutics (ELVN) | 1.6 | $5.3M | 208k | 25.54 | |
Avadel Pharmaceuticals Com Shs (AVDL) | 1.5 | $5.1M | 385k | 13.12 | |
Ionis Pharmaceuticals (IONS) | 1.2 | $3.9M | 97k | 40.06 |